Development of Novel MR Techniques Using Volunteer Participants
Launched by UNIVERSITY COLLEGE, LONDON · Jul 4, 2023
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on developing new techniques for magnetic resonance (MR) imaging, which is a type of scan used to create detailed images of the body. The researchers are looking for healthy volunteers to help test and improve these new scanning methods. By using volunteer participants, they aim to gather important information that will enhance the speed and quality of MR scans, making them even more useful for future medical research.
To participate, volunteers need to be healthy adults aged 18 and older, and they will be recruited through email from specific departments at UCL and UCLH. However, individuals with certain conditions—such as those with pacemakers, other implanted devices, or who might be pregnant—will not be able to take part. Participants can expect a safe and straightforward experience since MR imaging has been used safely on millions of people worldwide. It's important to note that the scans will only be used for research purposes and not for any personal medical care. All ethical guidelines will be followed to ensure the safety and well-being of everyone involved.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy volunteers will be recruited by email from within departments at UCL and UCLH
- • male or female
- • Aged 18 and above
- Exclusion Criteria:
- • volunteers with pacemakers or other implanted devices, or with other metallic foreign bodies, will be excluded.
- • Women who may be pregnant
- • any participants who cannot give informed consent (including anyone who may not adequately understand the verbal explanations or written information given in English)
About University College, London
University College London (UCL) is a leading global research institution renowned for its commitment to advancing healthcare through innovative clinical trials. As a prominent sponsor of clinical research, UCL leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous investigations aimed at improving patient outcomes and addressing pressing medical challenges. The institution fosters collaboration among researchers, healthcare professionals, and industry partners, ensuring that its trials adhere to the highest ethical standards and regulatory guidelines. UCL's dedication to translating scientific discoveries into practical applications underscores its role as a vital contributor to the advancement of medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported